Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 1 h ago
Peer-reviewedCC BY 4.0Frontiers in Medicine

Case Report: Delayed diagnosis of adult-onset Still’s disease after sepsis-like acute liver failure with macrophage activation syndrome

  1. 1The Eighth Clinical Medical College of Guangzhou University of Chinese Medicine, Foshan, China
  2. 2Foshan Hospital of Traditional Chinese Medicine, Foshan, China
  3. 3Department of Infectious Diseases, Foshan Hospital of Traditional Chinese Medicine, Foshan, China

Abstract

Background: Adult-onset Still's disease (AOSD) is a rare systemic autoinflammatory disease characterized by heterogeneous and nonspecific clinical manifestations. It often requires differentiation from infectious diseases, malignancies, and other rheumatic autoimmune disorders, making early diagnosis challenging. Acute liver failure (ALF) is a rare but severe complication of AOSD. AOSD may also be complicated by macrophage activation syndrome (MAS), a severe hyperinflammatory condition that can cause multiorgan dysfunction and mimic sepsis, further complicating diagnosis and management.

Case presentation: We report a 35-year-old woman with AOSD complicated by macrophage activation syndrome who initially presented with acute liver failure. Multiple pathogens were detected by metagenomic next-generation sequencing (mNGS), leading to an initial misdiagnosis of sepsis. Over the following two years, the patient experienced recurrent episodes of fever, rash, arthralgia, and liver dysfunction. After comprehensive evaluation, the diagnosis of AOSD was established according to the Yamaguchi criteria, and MAS was diagnosed based on the HLH-2004 criteria and HScore. The patient achieved clinical remission after high-dose glucocorticoid therapy and remained stable during follow-up.

Conclusions: This case highlights that AOSD complicated by MAS should be considered in patients with unexplained fever and acute liver failure, particularly those with hyperferritinemia, rash, and multisystem involvement. Even in the presence of evidence suggestive of infection, clinicians should remain vigilant for AOSD with MAS to avoid misdiagnosis and delayed treatment.

Related

  1. Macrophage Activation Syndrome Associated with Adult-onset Still's Disease Successfully Treated with Plasma Exchange and Canakinumab
    Wataru Kiyohara, Yuya Fujita, Muneyuki Hatta +12
    Internal MedicinePeer-reviewedCC BY-NC-NDFull textGeneral medicineJ-STAGE
  2. Breaking the Storm: Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome as the First Manifestation of Systemic Lupus Erythematosus/Mixed Connective Tissue Disease in an Adolescent Successfully Treated With Anakinra.
    Ramia Alhasan, Ahmad T Alenizi, Mahmoud Adly +3
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. When Flow Voids Are Missed: Delayed Diagnosis of Foix–Alajouanine Syndrome—A Case Report
    Dominika Jakubowicz-Lachowska, Mateusz Wierciński, Katarzyna Kapica-Topczewska +4
    Neurology internationalPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Diffuse gastrointestinal hemorrhage associated with emapalumab treatment of macrophage activation syndrome: A case report
    Samuel E. Hagman, Cary P. Cavender, David S. Willcutts
    JPGN reportsPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMCPMC
  5. Unmasking Huntington Disease: How a Neuropsychiatric Crisis Overcame Cultural Barriers to a Delayed Diagnosis
    Charles Donkor‐Baah, George Harold Kitson‐Mills, Stephen Annan Arthur +1
    Clinical case reportsPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
BibTeX
@article{quan2026case,
  title = {{Case Report: Delayed diagnosis of adult-onset Still’s disease after sepsis-like acute liver failure with macrophage activation syndrome}},
  author = {Ruolan Quan and Changlin Wang and Wei Li and Kaiping Jiang and Kaizhou Huang},
  journal = {Frontiers in Medicine},
  year = {2026},
  month = oct,
  doi = {10.3389/fmed.2026.1941213},
  url = {https://doi.org/10.3389/fmed.2026.1941213},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Case Report: Delayed diagnosis of adult-onset Still’s disease after sepsis-like acute liver failure with macrophage activation syndrome
AU  - Ruolan Quan
AU  - Changlin Wang
AU  - Wei Li
AU  - Kaiping Jiang
AU  - Kaizhou Huang
PY  - 2026
DA  - 2026/10/13
JO  - Frontiers in Medicine
DO  - 10.3389/fmed.2026.1941213
UR  - https://doi.org/10.3389/fmed.2026.1941213
AB  - Background: Adult-onset Still's disease (AOSD) is a rare systemic autoinflammatory disease characterized by heterogeneous and nonspecific clinical manifestations. It often requires differentiation from infectious diseases, malignancies, and other rheumatic autoimmune disorders, making early diagnosis challenging. Acute liver failure (ALF) is a rare but severe complication of AOSD. AOSD may also be complicated by macrophage activation syndrome (MAS), a severe hyperinflammatory condition that can cause multiorgan dysfunction and mimic sepsis, further complicating diagnosis and management.  Case presentation: We report a 35-year-old woman with AOSD complicated by macrophage activation syndrome who initially presented with acute liver failure. Multiple pathogens were detected by metagenomic next-generation sequencing (mNGS), leading to an initial misdiagnosis of sepsis. Over the following two years, the patient experienced recurrent episodes of fever, rash, arthralgia, and liver dysfunction. After comprehensive evaluation, the diagnosis of AOSD was established according to the Yamaguchi criteria, and MAS was diagnosed based on the HLH-2004 criteria and HScore. The patient achieved clinical remission after high-dose glucocorticoid therapy and remained stable during follow-up.  Conclusions: This case highlights that AOSD complicated by MAS should be considered in patients with unexplained fever and acute liver failure, particularly those with hyperferritinemia, rash, and multisystem involvement. Even in the presence of evidence suggestive of infection, clinicians should remain vigilant for AOSD with MAS to avoid misdiagnosis and delayed treatment.
SN  - 2296-858X
ER  -